Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Braun

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Psychosocial Intervention|August 6, 2025
Peer Support in Chronic Conditions from the Peer Supporters' Perspective: A Systematic ReviewAnnika Braun, Bernd Löwe, Natalie Uhlenbusch
Orphanet Journal of Rare Diseases|January 20, 2026
Optimizing recruitment in rare disease research: a cross-sectional online study evaluating sampling strategies for hard-to-reach populationsShalice Baffour, Bernd Löwe, Annika Braun, et al.
Frontiers in Oncology|July 16, 2024
Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cellsHanna Sentek, Annika Braun, Bettina Budeus, et al.
Digestive Diseases (Basel, Switzerland)|October 8, 2010
Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?Wolfgang Stremmel, Anja Hanemann, Robert Ehehalt, et al.
International Journal of Molecular Sciences|December 15, 2010
Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammationHannah Schneider, Annika Braun, Joachim Füllekrug, et al.
Biochimica Et Biophysica Acta|July 3, 2010
Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevanceRobert Ehehalt, Annika Braun, Max Karner, et al.
Journal of Clinical Gastroenterology|January 6, 2010
Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding studyWolfgang Stremmel, Annika Braun, Anja Hanemann, et al.
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Mucosal protection by phosphatidylcholineWolfgang Stremmel, Robert Ehehalt, Sabine Staffer, et al.
Expert Opinion on Investigational Drugs|November 26, 2010
Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis--a review of three clinical trialsWolfgang Stremmel, Anja Hanemann, Annika Braun, et al.
BMC Gastroenterology|February 11, 2009
Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitisAlexandra Zahn, Thomas Giese, Max Karner, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Psychosocial Intervention|August 6, 2025
Peer Support in Chronic Conditions from the Peer Supporters' Perspective: A Systematic ReviewAnnika Braun, Bernd Löwe, Natalie Uhlenbusch
Orphanet Journal of Rare Diseases|January 20, 2026
Optimizing recruitment in rare disease research: a cross-sectional online study evaluating sampling strategies for hard-to-reach populationsShalice Baffour, Bernd Löwe, Annika Braun, et al.
Frontiers in Oncology|July 16, 2024
Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cellsHanna Sentek, Annika Braun, Bettina Budeus, et al.
Digestive Diseases (Basel, Switzerland)|October 8, 2010
Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?Wolfgang Stremmel, Anja Hanemann, Robert Ehehalt, et al.
International Journal of Molecular Sciences|December 15, 2010
Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammationHannah Schneider, Annika Braun, Joachim Füllekrug, et al.
Biochimica Et Biophysica Acta|July 3, 2010
Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevanceRobert Ehehalt, Annika Braun, Max Karner, et al.
Journal of Clinical Gastroenterology|January 6, 2010
Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding studyWolfgang Stremmel, Annika Braun, Anja Hanemann, et al.
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Mucosal protection by phosphatidylcholineWolfgang Stremmel, Robert Ehehalt, Sabine Staffer, et al.
Expert Opinion on Investigational Drugs|November 26, 2010
Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis--a review of three clinical trialsWolfgang Stremmel, Anja Hanemann, Annika Braun, et al.
BMC Gastroenterology|February 11, 2009
Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitisAlexandra Zahn, Thomas Giese, Max Karner, et al.
Pageof 2